Parallax Volatility Advisers’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50,000
Closed -$1.06M 2884
2019
Q4
$1.06M Hold
50,000
﹤0.01% 1505
2019
Q3
$663K Buy
+50,000
New +$735K ﹤0.01% 1530
2019
Q2
Sell
-15,000
Closed -$288K 4120
2019
Q1
$288K Sell
15,000
-849,000
-98% -$13.7M ﹤0.01% 1732
2018
Q4
$12.3M Hold
864,000
0.02% 462
2018
Q3
$18M Buy
864,000
+74,800
+9% +$1.77M 0.02% 322
2018
Q2
$18.7M Buy
789,200
+779,200
+7,792% +$15.7M 0.03% 289
2018
Q1
$146K Sell
10,000
-815,200
-99% -$13.3M ﹤0.01% 1306
2017
Q4
$13.3M Buy
825,200
+30,300
+4% +$358K 0.02% 336
2017
Q3
$11.1M Sell
794,900
-195,100
-20% -$1.94M 0.02% 376
2017
Q2
$8.74M Buy
+990,000
New +$6.95M 0.02% 426

Other funds holding IMMU

Parallax Volatility Advisers's IMMU Position: Q3 2020 in Review

Parallax Volatility Advisers sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 23 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in IMMU in Q2 2017 and held it in 10 quarters. The position peaked at $3.64M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Parallax Volatility Advisers reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 23 Immunomedics Inc shares in Q3 2020, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Immunomedics Inc in Q2 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's Immunomedics Inc position peaked at $3.64M in Q2 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Parallax Volatility Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.